AstraZeneca
AstraZeneca's timeline holds 65 claims from 1995 to 2025: 56 money & deals, 9 other. 7 are undated. The latest took effect on .
Newest first, 15 years; a claim a later one replaced stays on the line, struck through. Current state →
Facts: headquarters · revenue · net income · operating income · across every company: headquarters, revenue, net income
· 5
- sec.gov, 1 source, claim clm_7F0BFE9EB1CDnet income 10,233,000,000 United States dollar
- sec.gov, 1 source, claim clm_763AA2791DE9operating income 13,743,000,000 United States dollar
- sec.gov, 1 source, claim clm_75285D1846DFrevenue 58,739,000,000 United States dollar
- sec.gov, 1 source, claim clm_B12E0C1D9275total assets 114,074,000,000 United States dollar
- sec.gov, 1 source, claim clm_327B10FB292Btotal equity 48,719,000,000 United States dollar
· 5
- to sec.gov, 1 source, claim clm_DCF412B5DDDAnet income 7,041,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_3994638C1B14operating income 10,003,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_5BDDB85A5719revenue 54,073,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_F05CE2B1D291total assets 104,035,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_702A322E3B09total equity 40,871,000,000 United States dollar (replaced)
· 5
- to sec.gov, 1 source, claim clm_9F87514064CDnet income 5,961,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_7E98BE75827Boperating income 8,193,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_1A1A4ACC29CBrevenue 45,811,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_CD9BD69D497Ftotal assets 101,119,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_91657DA81B37total equity 39,166,000,000 United States dollar (replaced)
· 5
- to sec.gov, 1 source, claim clm_AE6BE83BCC88net income 3,293,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_F928384EA602operating income 3,757,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_31557855C15Arevenue 44,351,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_A839065669A3total assets 96,483,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_CC377A6E41D1total equity 37,058,000,000 United States dollar (replaced)
· 5
- to sec.gov, 1 source, claim clm_F01EE117485Cnet income 115,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_10DEC07C1593operating income 1,056,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_47272A7D1B25revenue 37,417,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_BAB2B4420BCEtotal assets 105,363,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_515C40C5227Ctotal equity 39,287,000,000 United States dollar (replaced)
· 5
- to sec.gov, 1 source, claim clm_B737A429D7E9net income 3,144,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_D4ADC56D2F76operating income 5,162,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_85B6D134E13Crevenue 26,617,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_BFC9DC65FD19total assets 66,729,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_F30C48EE7B4Atotal equity 15,638,000,000 United States dollar (replaced)
· 5
- to sec.gov, 1 source, claim clm_529E4815C0D2net income 1,227,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_CA91157E8FECoperating income 2,924,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_08D5EE5A62C8revenue 24,384,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_010DB2BB1408total assets 61,377,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_7E8748E6B574total equity 14,596,000,000 United States dollar (replaced)
· 5
- to sec.gov, 1 source, claim clm_80CF1A157103net income 2,050,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_0928C69F436Coperating income 3,387,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_790001197E10revenue 22,090,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_39BC161464CEtotal assets 60,651,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_4F65B3C1FC28total equity 14,044,000,000 United States dollar (replaced)
· 5
- to sec.gov, 1 source, claim clm_7BDCCD2AEF61net income 2,868,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_77DE63410430operating income 3,677,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_B25F0718A827revenue 22,465,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_10CF439A8D3Dtotal assets 63,354,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_6A3694B18261total equity 16,642,000,000 United States dollar (replaced)
· 5
- to sec.gov, 1 source, claim clm_194B34501880net income 3,406,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_654CC8AE2812operating income 4,902,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_904F793B66AArevenue 23,002,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_4B2074B77E0Btotal assets 62,526,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_B272D51F85BCtotal equity 16,669,000,000 United States dollar (replaced)
· 5
- to sec.gov, 1 source, claim clm_DEF1603E885Bnet income 2,826,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_9CE71799FE73operating income 4,114,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_E7354F8FC4ABrevenue 24,708,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_39CC74EC0018total assets 60,056,000,000 United States dollar (replaced)
- to sec.gov, 1 source, claim clm_4F3F4354CA13total equity 18,509,000,000 United States dollar (replaced)
undated
- undatedsec.gov, 1 source, claim clm_8820826D4245SEC CIK 0000901832
- undatedsec.gov, 1 source, claim clm_433F982364C7fiscal year end 12-31
- undatedsec.gov, 1 source, claim clm_6B4DC8E0E36Aheadquarters Cambridge
- undatedsec.gov, 1 source, claim clm_43376D897A1Flisted on NYSE
- undatedsec.gov, 1 source, claim clm_26C4F27CEF84SIC industry Pharmaceutical Preparations (2834)
- undatedsec.gov, 1 source, claim clm_8352C183E226incorporated in X0
- undatedsec.gov, 1 source, claim clm_7F36A4D2B72Fticker AZN
/timelines/astrazeneca.md/v1/timelines/astrazeneca